WP
PROK icon

Woodline Partners’s ProKidney PROK Stock Holding History

Woodline Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$895K Hold
500,000
– – ﹤0.01% 898
2025
Q4 		$1.12M Buy
+500,000
New +$1.31M ﹤0.01% 834

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners's PROK Position: Q1 2026 in Review

Woodline Partners held its ProKidney (PROK) position steady in Q1 2026 at 500,000 shares worth $895K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Woodline Partners first reported a position in PROK in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.12M in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Woodline Partners held 500,000 shares of ProKidney worth $895K as of Q1 2026.
  • Woodline Partners left its ProKidney share count unchanged in Q1 2026.
  • ProKidney made up ﹤0.01% of Woodline Partners's portfolio in Q1 2026, its #898 holding.
  • Woodline Partners first reported a position in ProKidney in Q4 2025 and has held it in 2 quarters since.
  • Woodline Partners's ProKidney position peaked at $1.12M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.